---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-057684"
form_type: "8-K"
ticker: "LUDG"
cik: "0001960262"
company_name: "LUDWIG ENTERPRISES, INC."
filed_at: "2025-06-25T23:59:59+00:00"
generated_at: "2026-05-18T21:27:03.699691+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Ludwig Enterprises appoints Garth Lees-Rolfe as independent director

## Summary
- Garth Lees-Rolfe appointed independent director effective June 23, 2025.
- Over 19 years of finance/accounting experience; currently CFO of ABLi Therapeutics.
- Previously CFO of Inhibikase Therapeutics (NASDAQ: IKT) and VP Finance at F-Star (NASDAQ: FSTX).
- Spent 16 years at Ernst & Young, most recently as Senior Manager; holds CPA and Chartered Accountant licenses.
- No family relationships with existing directors or executive officers.

## SEC filing metadata
- accession: 0001213900-25-057684
- form_type: 8-K
- ticker: LUDG
- cik: 0001960262
- company_name: LUDWIG ENTERPRISES, INC.
- filed_at: 2025-06-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1960262/000121390025057684/0001213900-25-057684-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1960262/000121390025057684/ea0246925-8k_ludwig.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-057684
- JSON: https://secwatch.observer/filing/0001213900-25-057684.json
- Plain text: https://secwatch.observer/filing/0001213900-25-057684.txt

## Key facts
- Executive change
  Garth Lees-Rolfe was appointed as Independent Director at LUDWIG ENTERPRISES, INC..
  - Action: appointed
  - Role: Independent Director
  source text: On June 23, 2025, the Board appointed a new independent director, Garth Lees-Rolfe, to hold office until the earlier of the expiration of the term of office, a successor is duly elected and qualified, or the earlier of her death, resignation, disqualification, or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1960262/000121390025057684/0001213900-25-057684-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.